doxazosin

Generic: doxazosin

Labeler: pd-rx pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name doxazosin
Generic Name doxazosin
Labeler pd-rx pharmaceuticals, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

doxazosin mesylate 2 mg/1

Manufacturer
PD-Rx Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 43063-739
Product ID 43063-739_414b2f15-260c-42cb-e063-6394a90a5225
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA075580
Listing Expiration 2026-12-31
Marketing Start 2011-07-14

Pharmacologic Class

Classes
adrenergic alpha-antagonists [moa] alpha-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 43063739
Hyphenated Format 43063-739

Supplemental Identifiers

RxCUI
197626
UPC
0343063739907
UNII
86P6PQK0MU

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name doxazosin (source: ndc)
Generic Name doxazosin (source: ndc)
Application Number ANDA075580 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2 mg/1
source: ndc
Packaging
  • 90 TABLET in 1 BOTTLE, PLASTIC (43063-739-90)
source: ndc

Packages (1)

43063-739-90 90 TABLET in 1 BOTTLE, PLASTIC (43063-739-90)

Ingredients (1)

doxazosin mesylate (2 mg/1)

Linked Drug Pages (1)

Doxazosin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "414b2f15-260c-42cb-e063-6394a90a5225", "openfda": {"upc": ["0343063739907"], "unii": ["86P6PQK0MU"], "rxcui": ["197626"], "spl_set_id": ["2ea9bb6b-a4f0-496a-b27b-4454167a4b70"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET in 1 BOTTLE, PLASTIC (43063-739-90)", "package_ndc": "43063-739-90", "marketing_start_date": "20170131"}], "brand_name": "Doxazosin", "product_id": "43063-739_414b2f15-260c-42cb-e063-6394a90a5225", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "43063-739", "generic_name": "Doxazosin", "labeler_name": "PD-Rx Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Doxazosin", "active_ingredients": [{"name": "DOXAZOSIN MESYLATE", "strength": "2 mg/1"}], "application_number": "ANDA075580", "marketing_category": "ANDA", "marketing_start_date": "20110714", "listing_expiration_date": "20261231"}